Health
‘Strong Immune Response’ From One Dose of Pfizer Vaccine: Study – Medscape
Study suggests that two doses of vaccine are important, even in people who have previously tested positive for COVID.
People previously infected with SARS-CoV-2 showed higher antibody and T-cell responses after one dose of Pfizer’s BNT162b2 messenger (mRNA) vaccine compared with people who had a first dose without previously contracting the virus, according to research led by the universities of Sheffield and Oxford.
The early findings from the Protective Immunity from T cells to COVID-19 in Health workers study (PITCH) said the findings suggested that one dose of the vaccine protected against severe disease. That…
-
Business21 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Business24 hours ago5 easy steps to build a $100,000 ASX share portfolio
-
General23 hours agoWhy an Australian journalist is teaching meditation in America’s toughest jails
-
Noosa News22 hours ago“There’s No Going Back”: The Grid Meets the Real World in the Initial Trailer for Third ‘TRON’ Movie ‘Ares’